Genomic and geospatial epidemiology of Mycobacterium tuberculosis in Oman: first national insight using whole genome sequencing

Int J Infect Dis. 2023 May:130 Suppl 1:S4-S11. doi: 10.1016/j.ijid.2023.04.001. Epub 2023 Apr 17.

Abstract

Objectives: Mycobacterium tuberculosis (MTB) is a global public health issue. Although Oman reduced the burden of tuberculosis (TB) by 85% in under 25 years, the annual incidence rate remains stagnant. Whole genome sequencing (WGS) is used to investigate the transmission dynamics of MTB complex. This study aimed to resolve traditional genotype clusters and exploring the geospatial distribution to understand the epidemiology of TB in Oman.

Methods: Confirmed cases with spoligotyping clusters were randomly selected. WGS of 70 isolates were selected for final analysis. Correlation of epidemiological and geospatial data was conducted.

Results: A total of 233 cases were registered in 2021; 169 had confirmed growth, with an incidence rate of 5.2/100,000 population for 2021. A total of 70 genomes were analyzed, and five large clusters and three medium clusters were identified. The lineages L1, L2, L3, and L4 and several sublineages belonging to the Indo-Oceanic family and East African Indian family were identified as predominant in Oman. There were no multidrug-resistant cases identified.

Conclusion: There is a considerable genetic variation among the strains in Oman. This predominance could be linked with the high percentage of non-national population, which represents different countries and frequent traveling to high TB burden countries. WGS combined with geospatial investigations of MTB are required to better understand the disease transmission in Oman, which will support TB elimination efforts.

Keywords: Molecular epidemiology; Mycobacterium tuberculosis; Oman; Tuberculosis; Whole genome sequencing.

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Genomics
  • Genotype
  • Humans
  • Molecular Epidemiology
  • Mycobacterium tuberculosis* / genetics
  • Oman / epidemiology
  • Tuberculosis* / microbiology
  • Tuberculosis, Multidrug-Resistant* / epidemiology
  • Tuberculosis, Multidrug-Resistant* / microbiology
  • Whole Genome Sequencing

Substances

  • Antitubercular Agents